PSMA PET may potentially have a role in the preoperative staging of advanced renal cell carcinoma as PET detected multiple histologically proven metastatic lesions which were false negative on CT scanning, resulting in change in surgical strategies in some patients. The gene discussed is FOLH1; the disease is hereditary clear cell renal cell carcinoma.